Budget vs premium
MedVi vs Embody: Which Costs Less Over 12 Months? (2026)
MedVi costs $3,468 a year against $828 for Embody. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.6 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
MedVi and Embody sit at ranks 6 and 14 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
MedVi costs 4.3x more per month than Embody once promotional pricing is out of the picture ($299/mo against $69/mo). Over a year that gap compounds into real money, and the question is what it buys.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- Embody — $828 against $2,592 at MedVi, on each provider's own best published pricing.
- Most support for the money
- Embody — 24/7 support for dosing and side-effect questions.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Widest medication choice
- Embody — compounded semaglutide and compounded tirzepatide.
The short version: MedVi vs Embody
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| MedVi | Embody | |
|---|---|---|
| Advertised price | $179 promotional first month | Semaglutide $69/mo (was $299), tirzepatide $119/mo |
| Rate after promotions | $299/mo | $69/mo |
| Pricing structure | Promotional first month, then standard rate | Published rate per medication |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Fast, free shipping | Free shipping, 1-2 day delivery after approval |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | Not published | $119/mo |
| Patient reviews | 12,896 | 11,250 |
| eRxDoctor score | 9.2/10 | 7.6/10 |
Cost over a full course of treatment
Both providers lead with a number designed to get you through the intake. So the table works in the timeframe treatment actually happens in.
| MedVi | Embody | |
|---|---|---|
| First month | $179 | $69 |
| Months 2 onward | $299/mo | $69/mo |
| 6-month total | $1,674 | $414 |
| 12-month total | $3,468 | $828 |
| Best published plan | 3-month plan at $649 — $2,592/yr | No multi-month discount published |
Embody finishes the year $1,764 cheaper. For some patients the support MedVi bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
Where the extra money goes at MedVi
The gap runs to 4.3x a month. What MedVi offers for it: 24/7 support from certified medical professionals, plus fast, free shipping.
Embody counters with the lowest published semaglutide price on this list, with no lock-in, and the thing it asks you to accept in return: a limited-time rate with few of the extras that higher-priced platforms bundle.
The premium buys attention. If you expect to need it — first GLP-1, side effects you will want triaged quickly, a history of stalling around week ten — it is money well spent. If you do not, it is not.
A closer look at MedVi
The pitch is a genuinely low promotional entry point with 24/7 clinical support behind it. MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
Practically: simple online process, no clinic visits, fast, free shipping, and a pricing model that is promotional first month, then standard rate.
24/7 support from certified medical professionals. The formulary covers compounded semaglutide.
MedVi pros
- 24/7 support from certified medical professionals
- Simple online process with no clinic visits required
- Low promotional first month at $179 including fast, free shipping
- Clinically dosed compounded semaglutide
MedVi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic or Wegovy
- Semaglutide only, no tirzepatide option
Where it gives ground to Embody: the price roughly doubles to $299 once the promotional month ends.
Embody in detail
Semaglutide $69/mo (was $299), Tirzepatide $119/mo In this pairing, its distinguishing feature is the lowest published semaglutide price on this list, with no lock-in.
Intake is licensed provider review handled entirely online. Fulfillment is free shipping, 1-2 day delivery after approval. The commercial terms are published rate per medication, published upfront.
Support: 24/7 support for dosing and side-effect questions. The medications on offer are compounded semaglutide and compounded tirzepatide.
Embody pros
- 24/7 support access for dosing and side-effect questions
- Licensed provider review handled entirely online
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
Embody cons
- Final pricing may vary based on dose and clinician recommendation
- $69 semaglutide pricing is a limited-time offer that may increase
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
Read next to MedVi, the weak point: a limited-time rate with few of the extras that higher-priced platforms bundle.
MedVi or Embody: matching the program to the patient
Choose MedVi if:
- you want to start on their timeline: simple online process, no clinic visits
- the level of clinical contact suits you: 24/7 support from certified medical professionals
- what it leads on is worth paying for in your case: a genuinely low promotional entry point with 24/7 clinical support behind it
- you are willing to commit for a term in exchange for a lower effective rate (3-month plan at $649)
Choose Embody if:
- the twelve-month total is what you are optimizing ($828 against $3,468)
- you would get real value from the lowest published semaglutide price on this list, with no lock-in
- the monthly rate is the constraint — $69/mo against $299/mo
- you want tirzepatide available without changing provider later
What each one gives up
On price. Embody is the cheaper program at $69/mo against $299/mo. What Embody gives up for that is a limited-time rate with few of the extras that higher-priced platforms bundle; what MedVi charges for is a genuinely low promotional entry point with 24/7 clinical support behind it.
On access. MedVi advertises simple online process, no clinic visits and fast, free shipping; Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. Promotional first month, then standard rate at MedVi, against published rate per medication at Embody. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On clinical contact. MedVi provides 24/7 support from certified medical professionals. Embody provides 24/7 support for dosing and side-effect questions. Both are asynchronous-first services and neither replaces a physician who can examine you.
What the evidence actually says
Neither MedVi nor Embody manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
MedVi vs Embody: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, MedVi or Embody?
Embody, at $69 against $179. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, MedVi or Embody?
MedVi, with 12,896 against 11,250. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do MedVi or Embody take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with MedVi compared with Embody?
MedVi advertises simple online process, no clinic visits, with fast, free shipping. Embody advertises licensed provider review handled entirely online, with free shipping, 1-2 day delivery after approval. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Can I switch from MedVi to Embody later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date, and check the refund terms on any prepaid plan first.
The verdict
On the numbers, Embody wins the year: $828 against $2,592. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
The case for MedVi is a genuinely low promotional entry point with 24/7 clinical support behind it. That is worth $147 a month to some patients and nothing at all to others — be honest about which you are.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Hers vs MedViBrand-name vs compounded
- Shed vs MedViPublished price vs quote-only
- Embody vs Mochi HealthTirzepatide access
- Embody vs NoviBudget vs premium
- Embody vs MaximusBudget vs premium
- Embody vs He & She MDBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or Embody, and does not sell treatment. Read our ranking methodology.